WuXi to Bulk Up Cell Therapy Manufacturing in Philadelphia

SourceFierce Pharma Manufacturing
Date Published03/17/2015
Author NameEric Saganowsky
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name WuXi PharmaTech
Type of work Manufacturing
If manufacturing, is the company an OEM? Yes
Reshoring category:Transplant
Year reshoring announced:2015
Domestically, the work will be done:In-house
Capital investment ($):40
Country(ies) from which reshored:China
City reshored to:Philadelphia
State(s) reshored to:PA
If relevant, work nearshored to:-
Industry(ies):Medical Equipment/Supplies
Product(s) reshoredCell Therapy Products
What domestic positive factors made reshoring more attractive?Customer responsiveness improvement
Find Reshoring Articles